Classifications

• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B82—NANOTECHNOLOGY
  • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
  • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
  • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
  • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P19/00—Drugs for skeletal disorders
  • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Epidemiology (AREA)
• Nanotechnology (AREA)
• Medical Informatics (AREA)
• Crystallography & Structural Chemistry (AREA)
• General Chemical & Material Sciences (AREA)
• Molecular Biology (AREA)
• Rheumatology (AREA)
• Biophysics (AREA)
• Biotechnology (AREA)
• General Engineering & Computer Science (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Organic Chemistry (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Pain & Pain Management (AREA)
• Immunology (AREA)
• Orthopedic Medicine & Surgery (AREA)
• Physical Education & Sports Medicine (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicinal Preparation (AREA)
• Polysaccharides And Polysaccharide Derivatives (AREA)
• Plural Heterocyclic Compounds (AREA)

Applications Claiming Priority (1)

Publications (2)

Family

ID=29716770

Family Applications (1)

Country Status (26)

Families Citing this family (13)

Family Cites Families (6)

• 2002
  • 2002-06-17 AT AT02013251T patent/ATE359827T1/de active
  • 2002-06-17 SI SI200230568T patent/SI1374906T1/sl unknown
  • 2002-06-17 ES ES02013251T patent/ES2286177T3/es not_active Expired - Lifetime
  • 2002-06-17 DE DE60219609T patent/DE60219609T2/de not_active Expired - Lifetime
  • 2002-06-17 EP EP02013251A patent/EP1374906B1/en not_active Expired - Lifetime
  • 2002-06-17 PT PT02013251T patent/PT1374906E/pt unknown
• 2003
  • 2003-06-12 RU RU2004136988/15A patent/RU2316350C2/ru active
  • 2003-06-12 PL PL373873A patent/PL218414B1/pl unknown
  • 2003-06-12 US US10/516,945 patent/US7700579B2/en not_active Expired - Lifetime
  • 2003-06-12 KR KR1020047008384A patent/KR101079484B1/ko not_active Expired - Lifetime
  • 2003-06-12 HR HRP20041192AA patent/HRP20041192B1/hr not_active IP Right Cessation
  • 2003-06-12 WO PCT/EP2003/006142 patent/WO2003105906A1/en not_active Ceased
  • 2003-06-12 EP EP03738016A patent/EP1513556B1/en not_active Expired - Lifetime
  • 2003-06-12 CN CNB038173565A patent/CN100352444C/zh not_active Expired - Lifetime
  • 2003-06-12 MX MXPA04012502A patent/MXPA04012502A/es active IP Right Grant
  • 2003-06-12 CA CA002489708A patent/CA2489708A1/en not_active Abandoned
  • 2003-06-12 AU AU2003245931A patent/AU2003245931A1/en not_active Abandoned
  • 2003-06-15 JO JO200367A patent/JO2533B1/en active
  • 2003-06-16 MY MYPI20032243A patent/MY134691A/en unknown
  • 2003-06-16 TW TW092116236A patent/TWI341731B/zh not_active IP Right Cessation
  • 2003-07-27 SA SA03240220A patent/SA03240220B1/ar unknown
• 2004
  • 2004-02-10 NO NO20040601A patent/NO332262B1/no not_active IP Right Cessation
  • 2004-12-10 TN TNP2004000245A patent/TNSN04245A1/en unknown
  • 2004-12-15 ZA ZA200410142A patent/ZA200410142B/xx unknown
  • 2004-12-16 IL IL16579704A patent/IL165797A0/xx unknown
  • 2004-12-17 MA MA28012A patent/MA27367A1/fr unknown
• 2007
  • 2007-07-09 CY CY20071100907T patent/CY1107693T1/el unknown

Also Published As

Similar Documents